He D - Search Results

1

The mechanism of DAB2IP in chemoresistance of prostate cancer cells.

Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao G, Fazli L, Gleave M, He D, Boothman DA, Hsieh JT. Wu K, et al. Among authors: he d. Clin Cancer Res. 2013 Sep 1;19(17):4740-9. doi: 10.1158/1078-0432.CCR-13-0954. Epub 2013 Jul 9. Clin Cancer Res. 2013. PMID: 23838317 Free PMC article.

2

[Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].

Luo Y, He DL, Ning L, Zhu GD, Shen SL. Luo Y, et al. Zhonghua Nan Ke Xue. 2006 Mar;12(3):230-3. Zhonghua Nan Ke Xue. 2006. PMID: 16597039 Chinese.

3

[Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].

Luo Y, He DL, Ning L. Luo Y, et al. Zhonghua Nan Ke Xue. 2006 Aug;12(8):696-700. Zhonghua Nan Ke Xue. 2006. PMID: 16970156 Chinese.

4

[Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials].

Zhang LL, He DL, Li X, Li L, Zhu GD, Wang XY. Zhang LL, et al. Zhonghua Nan Ke Xue. 2006 Oct;12(10):913-6. Zhonghua Nan Ke Xue. 2006. PMID: 17121023 Chinese.

5

PrLZ is expressed in normal prostate development and in human prostate cancer progression.

Wang R, Xu J, Mabjeesh N, Zhu G, Zhou J, Amin M, He D, Marshall FF, Zhau HE, Chung LW. Wang R, et al. Among authors: he d. Clin Cancer Res. 2007 Oct 15;13(20):6040-8. doi: 10.1158/1078-0432.CCR-07-0640. Clin Cancer Res. 2007. PMID: 17947466

6

[Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].

Zhu GF, Cheng HP, Wu KJ, Zhang LL, Zhu GD, Zhang D, He DL. Zhu GF, et al. Among authors: he dl. Zhonghua Nan Ke Xue. 2008 Mar;14(3):238-41. Zhonghua Nan Ke Xue. 2008. PMID: 18488338 Chinese.

7

A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells.

Zhang LL, Li L, Wu DP, Fan JH, Li X, Wu KJ, Wang XY, He DL. Zhang LL, et al. Acta Pharmacol Sin. 2008 Sep;29(9):1060-8. doi: 10.1111/j.1745-7254.2008.00831.x. Acta Pharmacol Sin. 2008. PMID: 18718175

8

PrLZ expression is associated with the progression of prostate cancer LNCaP cells.

Li L, Zhang D, Zhang L, Zhu G, Sun Y, Wu K, Wang X, He D. Li L, et al. Among authors: he d. Mol Carcinog. 2009 May;48(5):432-40. doi: 10.1002/mc.20481. Mol Carcinog. 2009. PMID: 18800346

9

[Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].

Wu KJ, Zhang D, Zhu GF, Cheng HP, Zeng J, Zhang LL, Wang XY, He DL. Wu KJ, et al. Among authors: he dl. Zhonghua Nan Ke Xue. 2009 Jan;15(1):41-4. Zhonghua Nan Ke Xue. 2009. PMID: 19288748 Chinese.

10

[Identification of Wnt/beta-catenin signal pathway in human prostate cancer cell lines and its significance].

Jiang YG, Zhao JH, Luo Y, He DL, Wang XY, Cui XH. Jiang YG, et al. Zhonghua Nan Ke Xue. 2009 Apr;15(4):310-3. Zhonghua Nan Ke Xue. 2009. PMID: 19472902 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,972 results

Search Page

Filters